Funded Startups in Nord-Pas-de-Calais
The disclosed rounds in Nord-Pas-de-Calais are led by Exotec’s $337M Series D on 2022-01-17; it dwarfs the next-largest disclosed amounts, including Positi…
The disclosed rounds in Nord-Pas-de-Calais are led by Exotec’s $337M Series D on 2022-01-17; it dwarfs the next-largest disclosed amounts, including Positive Group’s $140M (2022-11-08) and The Future Is NEUTRAL’s $140M (2024-10-03). At the low end, natif. closed a $110K Seed round on 2023-05-30, sitting far below most other disclosed rounds.
Several clusters are visible. City-wise, Lille appears repeatedly (e.g., VizioSense $3M on 2025-07-08; Gravitee $60M on 2025-05-20; Everysens $7M on 2023-05-09), and the list spans from Axorus (2020-07-17, $400K) through the most recent Fascent (2026-06-22, $2M), with a concentration of activity in 2025 (many rounds dated 2025-05-20 to 2025-10-24). Sector and classification are also mixed: Biotechnology (4+ entries) coexists with multiple rounds labeled “Series Unknown” (12 entries) alongside a single “undisclosed” amount (Skillberg on 2026-05-18).
Most recent rounds
33 shownRelated listings
Frequently asked
What’s the largest disclosed round in this Nord-Pas-de-Calais list, and how does it compare with the rest?
Exotec’s $337M Series D on 2022-01-17 is the outlier above all other disclosed rounds. The next-largest disclosed amounts are $140M for Positive Group (2022-11-08) and The Future Is NEUTRAL (2024-10-03), while many other disclosed rounds sit well below $50M (for example, Lattice Medical at $50M on 2025-10-24).
Which locations look over-represented, and do they cluster around a particular city?
Lille is the most frequent city in the rows, including Gravitee ($60M, 2025-05-20), Everysens ($7M, 2023-05-09), and VizioSense ($3M, 2025-07-08). Other cities appear, but less consistently (e.g., Loos shows up with multiple biotechnology/AI entries like Axomove $5M on 2026-04-22 and GENFIT $30M on 2025-05-20).
Are there any dense date windows in the most recent activity?
Yes. Several notable rounds land in late spring 2025: Gravitee closes $60M (2025-05-20) and GENFIT closes $30M (2025-05-20), following other 2025 mid-year rounds like VizioSense ($3M, 2025-07-08) and Lattice Medical ($50M, 2025-10-24).
How many entries have ambiguous or missing round sizing, and where do the exceptions show up?
There are 12 rows labeled “Series Unknown” (for example, 4Moving Biotech $14M on 2026-02-10 and GENFIT $30M on 2025-05-20). Separately, only one row uses “undisclosed” for amount—Skillberg on 2026-05-18.
What stage mix dominates, and are there major early-stage vs later-stage patterns?
Later-stage rounds are present but not dominant; Seed and Series A rounds recur frequently (e.g., Fascent as Angel with $2M on 2026-06-22; Alteva Pre-Seed $2M on 2025-01-20; Axomove Series A $5M on 2026-04-22). Meanwhile, the biggest disclosed outliers come from later stages at the high end—Exotec’s Series D ($337M, 2022-01-17) and Gravitee’s Series C ($60M, 2025-05-20).
Which sector appears most repeatedly, and does it align with the bigger disclosed rounds?
Biotechnology appears in multiple entries, including 4Moving Biotech ($14M, 2026-02-10), Lattice Medical ($50M, 2025-10-24), GENFIT ($30M, 2025-05-20), and Stane ($11M, 2023-09-19). Larger disclosed biotech amounts include Lattice Medical’s $50M and GENFIT’s $30M, though the overall maximum in the list remains Exotec ($337M, Hardware) on 2022-01-17.
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.